vTv Therapeutics (VTVT) Shares Outstanding (2015 - 2026)

vTv Therapeutics has disclosed Shares Outstanding across 12 years of filings, most recently posting $3.9 million for Q1 2026.

• Shares Outstanding for Q1 2026 came in at $3.9 million, up 50.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.9 million (up 50.78% YoY), and the FY2025 annual result was $3.9 million, up 582.2% from the prior year.
• Shares Outstanding came in at $3.9 million for Q1 2026 at vTv Therapeutics, roughly flat from $3.9 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $81.5 million in Q3 2022 to a low of $577108.0 in Q1 2026.
• The 5-year median for Shares Outstanding is $2.4 million (2024), against an average of $9.1 million.
• Across the five-year window, Shares Outstanding plunged 97.44% in 2023 and surged 582.2% in 2025, its largest moves.
• vTv Therapeutics' Shares Outstanding stood at $2.1 million in 2022, then changed by 0.0% to $2.1 million in 2023, then tumbled by 72.31% to $577349.0 in 2024, then soared by 582.2% to $3.9 million in 2025, then changed by 0.0% to $3.9 million in 2026.
• The last three Shares Outstanding figures came in at $3.9 million (Q1 2026), $3.9 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.